Compare ArcelorMittal SA (MT) vs Novartis AG (NVS) Price & Performance

ArcelorMittal SATrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

ArcelorMittal SA vs Novartis AG — how do they compare? ArcelorMittal SA trades at $66.25 (market cap $50.01B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 5.8× ArcelorMittal SA's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

	MT	NVS
Market Cap	$50.01B	$290.25B
Sector	Basic Materials	Health
52-Week High	$71.65	$168.62
52-Week Low	$30.39	$113.50
Enterprise Value	$59.33B	$330.27B
Dividend Yield	0.91%	3.17%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

View details →

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 1 day agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 5 days agoBullish View details →

About ArcelorMittal SA

ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.